Delivery Order SPE2DB22D2007-SPE2DB25FJ4VB
- Not listed
- The Defense Logistics Agency awarded a $19,295.10 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a biologic medication used primarily to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on September 3, 2025, with an ultimate completion date of September 4, 2025, indicating expedited fulfillment requirements. The product will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a $39,105.45 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-competitive delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one...
- The Defense Logistics Agency awarded a delivery order valued at $10,782.12 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in rheumatoid arthritis treatment. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $19,280.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis treatment. This non-set-aside contract was competitively awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls...
- The Defense Logistics Agency awarded a delivery order valued at $3,594.04 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This firm fixed price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a purchase under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The contract carries no...
- The Defense Logistics Agency awarded a $42,265.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in rheumatoid arthritis treatment. The contract, which was not set-aside and competitively awarded, has an ultimate completion date of August 21, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $17,050.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract was competitively awarded with no set-aside designation and has an ultimate completion date of September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $24,594.08 to AmerisourceBergen Drug Corp for the supply of Orencia Clickject 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. Issued on July 31, 2025, with an ultimate completion date of August 1, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contractor will fulfill this order from its corporate office location in...
- The Defense Logistics Agency awarded a $20,371.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The award, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive contract. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $28,511.98 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract, awarded on August 11, 2025, with completion targeted for August 12, 2025, utilized firm fixed pricing with no set-aside designation, indicating competitive award to the qualified vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4VBDelivery Order
The Defense Logistics Agency awarded a $11,053.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a biologic medication used primarily for rheumatoid arthritis treatment. The contract, awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive, non-set-aside delivery order executed through the company's existing DLA contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the same location designated as the place of performance—is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award demonstrates AmerisourceBergen's established capability and competitive positioning as a primary pharmaceutical supplier within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 9/10/25 |